Ads
related to: mercksiemens.com has been visited by 10K+ users in the past month
Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 1 day agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 7 days agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 14 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Merck KGaA's Dividend Analysis
GuruFocus.com via Yahoo Finance· 5 days agoMerck KGaA (MKKGY) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29. As investors...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 1 day agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Michael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks By Investing.com
Investing.com· 10 hours agoMichael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks
Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 4 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for shares of
Is Merck Stock Fully Valued At $130?
Forbes· 3 days agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 2 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...